How Often Will the FTC Use Its Recently Reaffirmed Authority to Compel Disgorgement?

by K&L Gates LLP
Contact

K&L Gates LLP

The U.S. District Court for the Eastern District of Pennsylvania recently granted the Federal Trade Commission’s (“FTC”) request to compel a branded pharmaceutical company to disgorge $448 million in profits. The court held that the company obtained the profits by pursuing unfounded patent claims against potential generic drug competitors in “sham litigation.” The profits which the court found were obtained by the defendant through sham litigation are to be paid to the FTC and thereafter returned to consumers. The court rejected arguments that a recent Supreme Court opinion limiting securities law sanctions implied limitations on the FTC’s disgorgement authorities. Nevertheless, the recent turnover in commissioners at the FTC leaves in question how often the FTC will exercise its disgorgement powers.

The Underlying Dispute

AbbVie, Inc. (“AbbVie”), and certain of its subsidiaries, as well as Besins Healthcare, Inc. (“Besins”), jointly own a patent covering AndroGel, a brand-name, transdermal testosterone replacement drug. The FTC alleged that AbbVie and Besins unlawfully maintained their monopoly in the U.S. market for transdermal testosterone replacement drugs by pursuing sham patent litigation against two generic drug companies. A party litigating patent claims against a competitor is ordinarily immune from antitrust claims, pursuant to the First Amendment and the Noerr-Pennington [1] doctrine, which includes litigation within the First Amendment’s protection for petitioning the government for relief. However, there is no such protection where the litigation is “a mere sham to cover….an attempt to interfere directly with the business relationships of a competitor.” [2] This “sham litigation” exception encompasses situations in which (i) a defendant intends to cause the ongoing conduct of a governmental process like litigation — as opposed to a successful outcome of the process — to restrain competition, and (ii) no reasonable person could realistically expect success on the merits of the claim. [3]

The court had found that AbbVie and Besins had no reasonable prospect of prevailing on their patent claim because, although the generic product used the same active ingredient as the patented branded product, it used a different penetration enhancer than the only such enhancer covered by the patent. Thus, the composition of the generic medication was sufficiently different from AndroGel as to be outside the literal scope of the patent. Further, according to the court, the branded companies were estopped by the prosecution history from asserting that the generic drugs were sufficiently similar to fall within the doctrine of equivalents. The district court also found that the defendants intended to use the pendency of the litigation to delay entry by the generics.

The FTC alleged that the sham litigation had allowed AbbVie and Besins to generate higher profits on AndroGel than would have been the case if the sham patent litigation had not kept one or more generics out of the market. Not only did the branded AndroGel avoid losing share to the generic products, but it avoided the price decline that typically occurs in the market for a pharmaceutical once a general version is introduced.

The Order of Disgorgement

Section 13(b) of the Federal Trade Commission Act (the “Act”) provides that the FTC may sue in federal court to enjoin any conduct that is violating or is about to violate the Act. The district court is authorized to enter temporary restraining orders, preliminary injunctions, and final injunctions against such conduct. The Eastern District of Pennsylvania held that Section 13(b) of the Act, in its general authorization of equitable relief, is broad enough to encompass disgorgement without any specific reference to such a remedy. Quoting to a Supreme Court interpretation of similar provisions in the Fair Labor Standards Act, the court stated:

When Congress entrusts to an equity court the enforcement of prohibitions contained in a regulatory enactment, it must be taken to have acted cognizant of the historical power of equity to provide complete relief in the light of statutory purposes.

“This language,” the district court said, “in our view is equally applicable here to the FTC Act.” Absent the availability of disgorgement, the court reasoned, a monopolist would “be able to retain its ill-gotten gains and simply face an injunction against future wrong-doing, but even then only if the wrong-doing is continuing or likely to continue.” [4]

The district court rejected the defendants’ argument that the Supreme Court’s opinion in Kokesh v. SEC [5] restricted the FTC’s authority to seek disgorgement. In Kokesh, the U.S. Securities and Exchange Commission (“SEC”) had sought to compel an alleged securities law violator to disgorge profits received in the 14 years preceding the filing of the SEC’s complaint. The relevant securities statute, similar to Section 13(b), stated only that the SEC had the power to obtain injunctive relief or mandatory civil penalties. The Supreme Court held that, since disgorgement is a penalty, the five-year statute of limitations in 28 U.S.C. § 2462 relating to “an action, suit or proceeding for the enforcement of any civil fine, penalty or forfeiture” applied to the SEC’s disgorgement claim. Further, in a footnote the Supreme Court stated, “Nothing in this opinion should be interpreted as an opinion on whether courts possess authority to order disgorgement in SEC enforcement proceedings or on whether courts have properly applied disgorgement principles in this context.” Relying in part of that footnote, the defendants in AbbVie argued that disgorgement was beyond the FTC’s authority because Section 13(b) authorizes only injunctive relief. The district court, however, declined to read the Kokesh opinion as preventing it from granting the “well-established equitable relief of disgorgement.” [6]

In ordering disgorgement, “a court may exercise its equitable power only over the property causally related to the wrongdoing.” [7] This involves a two-step process in which the government must establish a reasonable approximation of the profits resulting from the violation and then the burden shifts to the defendant to show that the government’s approximation of profits is unreasonable. Then the court may add prejudgment interest. In this instance, that required the court to determine when each generic entrant would have entered the market absent the sham litigation, how quickly each entrant would have grabbed market share from the monopolist, how quickly prices would have fallen, and how long the monopolist’s market position continued to benefit from the effects of the sham litigation. Resolving those factual questions, the court determined that the defendants’ additional profits resulting from the sham litigation were $448 million and ordered disgorgement of that amount.

How Often Will the FTC Assert Its Disgorgement Authority?

In 2012, with a majority of Democratic members, the FTC withdrew its Policy Statement on Monetary Equitable Remedies in Competition Cases, which the FTC had unanimously adopted in 2003. [8] The 2012 Withdrawal Notice suggested an intent to pursue disgorgement or restitution more frequently in competition cases. The 2003 Policy Statement had stated that the FTC “do not view monetary disgorgement or restitution as routine remedies for antitrust cases.” [9] The 2003 Policy Statement set forth three principles that the FTC would employ in deciding whether to seek restitution or disgorgement in antitrust cases: (1) it would seek such relief only when the underlying antitrust violation is clear, based on existing precedent; (2) it would seek such relief only when there is a reasonable basis for calculating the amount of the remedial payment; and (3) it would consider the value of seeking monetary relief in light of any other available remedies, including private rights of action.

In withdrawing the 2003 Policy Statement by a 3–2 majority, the three Democratic members in 2012 stated that the 2003 Policy Statement took an “overly restrictive view of the Commission’s options for equitable remedies.” They reasoned that disgorgement and restitution serve both to deprive wrongdoers of the benefit of their wrongdoing and to restore victims to the position they would have enjoyed absent the wrongful conduct. “[W]hile disgorgement and restitution are not appropriate in all cases, we do not believe they should apply only in ‘exceptional cases’ as previously set out in the [2003] Policy Statement.” Indeed, “competition cases may often be appropriate candidates for monetary equitable relief.” The assertion of a claim for monetary equitable relief, according to the 2012 Withdrawal Notice, would be evaluated on a case-by-case basis, guided by existing case law regarding such remedies. [10]

Then-Commissioner Ohlhausen, a Republican, dissented from the Withdrawal Notice, endorsing the 2003 Policy Statement’s three factors for evaluating the pursuit of monetary equitable relief. [11] Later, in February 2017, as then-Acting Chairman, Ohlhausen declared, “Time and again [after the 2012 Withdrawal Notice, the FTC] elected to forego administrative litigation in conduct matters in favor of federal court, which is where the money is,” since monetary equitable relief can be obtained only in federal district court and not in FTC administrative proceedings. [12] She favored the adoption of new guidelines similar to the 2003 Policy Statement. Further, Commissioner Ohlhausen and then-Commissioner Joshua Wright, also a Republican, jointly issued a statement regarding their concurrence in the FTC’s acceptance of a consent order in FTC v. Cephalon, Inc., [13] which included disgorgement. While expressing their concern about the lack of a policy statement regarding the circumstances in which the FTC will seek disgorgement, they explained that they endorsed a disgorgement remedy in that case because it would meet the factors set forth in the withdrawn 2003 Policy Statement. [14] Commissioner Wright further explained that optimal deterrence of anticompetitive conduct (while avoiding over-deterrence of potentially pro-competitive behavior) means that disgorgement should not be imposed for misconduct with a high probability of detection and punishment or for conduct with plausible efficiency justifications.

Five new commissioners have now been confirmed by the Senate, three Republican and two Democratic. [15] What position the new commissioners will take regarding disgorgement remains to be seen. Some indication may be available, however, from the FTC’s handling of a July 31, 2018 consent decree in an administrative proceeding against alleged collusion among therapist staffing companies with respect to the compensation they pay to therapists. According to the complaint, after a home health agency advised the staffing companies that it was reducing the rate it was paying to the staffing companies, two staffing companies colluded to reduce their pay rate to the therapists they contracted with to provide services. The complaint was resolved through an agreed order requiring the parties to cease and desist from colluding on compensation. [16] Although the matter was resolved in an administrative proceeding and not in federal court where the FTC’s equitable powers under Section 13(b) are available, Commissioner Chopra filed a statement noting that the conduct at issue “was a clear violation of law” and that his fellow commissioners were preparing to resolve the matter in a manner “that does not include any notice or restitution to those targeted by this unlawful conduct, nor any admission of liability.” He opined, “While in some situations this may be appropriate, the Commission would benefit from hearing from the public on whether it should follow this approach on this and future matters, especially those involving our country’s growing ‘big economy.’” [17]

European Law Also Recognizes the Concept of Protecting a Dominant Market Position Through Vexatious Litigation but Does Not Provide for Disgorgement

In Europe, the European Union courts recognize that “sham litigation” or “vexatious litigation” may constitute, in wholly exceptional circumstances, an abuse of a dominant position contrary to Article 102 of the Treaty on the Functioning of the European Union (the equivalent of Section 2 of the Sherman Act). In its seminal ITT Promedia v. Commission judgment, the General Court of the European Union (“CGEU”) clarified that “wholly exceptional circumstances” arise: (i) where the litigation cannot reasonably be considered as an attempt to establish the rights of the claimant and would therefore serve only to “harass” the opposite party, and (ii) where the litigation is part of a plan whose aim is to eliminate competition. [18] This approach has been recently confirmed in Protégé International Ltd v Commission, [19] where the GCEU noted that the two conditions of ITT Promedia should be interpreted restrictively in order not to jeopardize the application of the general principle of European Union law on access to justice and that the conditions are cumulative. National competition authorities in the European Union have also employed the same approach for a pattern of complex conduct to exclude competitors that included patent-related litigation before civil and administrative courts. [20] The key piece of evidence in identifying vexatious litigation was the absence of genuine interest in receiving judicial relief.

Nevertheless, with respect to patent litigation in the pharmaceutical sector in the European Union, the European Commission (the “Commission”) in Astra Zeneca and then the GCEU refused to apply ITT Promedia and to characterize the contested conduct as vexatious litigation, notwithstanding the fact that there was a pattern of litigation related to the supplementary protection certificates (“SPC”) from which Astra Zeneca benefited in order to prevent or delay generic competition to its ulcer treatment drug, Losec. Astra Zeneca had submitted misleading information to national patent offices in order to acquire SPCs, which extended the patent protection for Losec and then defended those in court. Although there was the theoretical possibility that both of the ITT Promedia conditions were satisfied in Astra Zeneca, the Commission chose to put forward a separate type of abuse of dominant position, relying on the initially misleading representations made by Astra Zeneca before the patent offices which led to the granting of the SPCs. [21] This approach was upheld by the GCEU. [22]

It should be noted that in ITT Promedia, as well as in Protégé International, the GCEU referred to “wholly exceptional circumstances” instead of the usual reference to “exceptional circumstances,” indicating that the finding of an abuse in the context of intellectual property litigation is likely to be more difficult. This also suggests that the conditions for “vexatious” litigation will be more strictly interpreted than for other types of abuse (e.g., unilateral refusals to deal). This cautious approach at the European Union level has been clearly illustrated in Astra Zeneca, where both the Commission and the CGEU declined to put forward a theory of harm based on vexatious litigation but rather opted for another type of abuse to challenge Astra Zeneca’s conduct. As a result, in the context of intellectual property litigation, the two prongs of the ITT Promedia test are likely to be interpreted and applied restrictively so as to not frustrate the general principle of access to courts.

In Europe, “vexatious litigation,” if proven to amount to an abuse of dominant position, would result in the imposition of a fine up to 10% of the global turnover of the dominant company in the last financial year. Notably, fines are not intended to amount to a disgorgement of profits per se. The fines may be more or less than the actual profit made by the entity engaging in the vexatious litigation.


[1] E. R.R. Presidents Conference v. Noerr Motor Freight, 365 U.S. 127 (1961); United Mine Workers v. Pennington, 381 U.S. 657 (1965).

[2] Noerr, 365 U.S. at 144.

[3] Prof’l Real Estate Inv’rs v. Columbia Pictures Indus., 508 U.S. 49, 60–67 (1993).

[4] See also FTC v. Cephalon, Inc., 100 F. Supp. 3d 433, 439 (E.D. PA 2015).

[5] 137 S. Ct 1635 (2017).

[6] Slip op. at 79. The U.S.D.C. for the M.D. Fla. had earlier rejected the Kokesh argument in a case under Section 13(b) in a case involving the FTC’s consumer protection mission. FTC v. J. William Entr., LLC, 283 F. Supp. 3d 1259 (M.D. Fla. 2017).

[7] Slip op. at 81, quoting Commodity Futures Trading Comm’n v. Am. Metals Exch. Corp., 991 F.2d 71, 78–79 (3rd Cir. 1993). Cf. FTC v. Magazine Sols. LLC, 432 Fed. App’x 155, 158 (3rd Cir. 2011). (In consumer protection cases, the courts have upheld restitution up to the gross revenue resulting from the improper conduct.).

[8] Statement of the Commission, Effecting the Withdrawal of the Commission’s Policy Statement on Monetary Equitable Remedies in Competition Cases, 77 Fed. Reg. 47070 (Aug. 7, 2012), withdrawing Policy Statement on Monetary Equitable Remedies in Competition Cases, 68 Fed. Reg. 45,820 (Aug. 4, 2003) [the “Withdrawal Notice”].

[9] Policy Statement on Monetary Equitable Remedies in Competition Cases, 68 Fed. Reg. at 45, 82.

[10] 77 Fed. Reg. at 47070-02.

[11] Id. at 47071-2.

[12] M. K. Ohlhausen, The FTC’s Path Ahead (Feb. 3, 2017), https://www.ftc.gov/system/files/documents/public_statements/1070123/gcr_the-ftc_path_ahead.pdf.

[13] FTC v. Cephalon, Inc., Stipulated Order, Civil Action No. 08-cv-2141 (E.D. Pa., June 17, 2015), https://www.ftc.gov/system/files/documents/cases/150617cephalonstip.pdf.

[14] Separate Statement of Commissioners Maureen Ohlhausen and Joshua D. Wright in Cephalon (May 28, 2015), https://www.ftc.gov/system/files/documents/public_statements/645501/150528cephalonohlhausenwright1.pdfSee also Dissenting Statement of Commissioner Joshua D. Wright in Cardinal Health, Inc., Fed No. 101-0006 (April 17, 2015), https://www.ftc.gov/system/files/documents/public_statements/637771/150420cardinalhealthwright.pdf.

[15] Commissioner (formerly Acting Chairman) Ohlhausen remains with the FTC until her term expires in September 2018 or her nomination as a judge in the U.S. Court of Federal Claims remains pending. Christine S. Wilson has been confirmed to take her seat at the FTC.

[16] In the Matter of Your Therapy Source LLC, FTC Docket No. 1710134, Complaint, www.ftc.gov/system/files/documents/cases/1710134_your_therapy_source_complaint_7-31-18.pdf and Decision and Order, www.ftc.gov/system/files/documents/cases/1710134_your_therapy_source_decision_and_order_7-31-18.pdf.

[17] Statement of Commissioner Chopra, https://www.ftc.gov/system/files/documents/public_statements/1396706/1710134_your_therapy_source_statement_of_commissioner_chopra_7-31-18.pdf.

[18] Case T-111/96 ITT Promedia NV v. Comm’n (1998) ECR II-2937.

[19] Case T-119/09 Protégé Int’l, ECLI:EU:T:2012:421.

[20] See, e.g., Decision of the Italian Competition Authority of January, 11 2012, in Case A431- Ratiopharm/Pfizer, Bulletino note 2/2012, annulled by the Regional Administrative Court of Lazio, I, decision No. 7467 (September 3, 2012), but reaffirmed by Council of State, order No. 2790 (May 22, 2013).

[21] Decision of the European Commission of June 15, 2005, in Case COMP/A.37.507/F3, Astra Zeneca, 2006 O.J. (L 332).

[22] Case T-321/05, Astra Zeneca v. Comm’n [2010] ECR II-2805.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© K&L Gates LLP | Attorney Advertising

Written by:

K&L Gates LLP
Contact
more
less

K&L Gates LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.